""	"submission_name"	"submission_date"	"template_name"	"tissue_type"	"response_agent_original"	"response_agent"	"proterm_and_extra"	"fully_qualified_response_agent"	"response_behavior_type"	"response_behavior"	"subgroup"	"time_point"	"time_point_units"	"vaccine_year"	"exposure_material_text"	"exposure_material"	"additional_exposure_material"	"comparison"	"baseline_time"	"cohort"	"publication_reference"	"publication_year"	"signature_source"	"comment"	"publication_reference_url"	"subObsID"	"uniqObsID"	"target_pathogen_1"	"target_pathogen_2"	"target_pathogen_3"	"signature_file"
"subject"	""	""	""	"cell_subset"	""	"cell_subset"	""	""	""	""	""	""	""	""	""	"vaccine"	""	""	""	""	""	""	""	""	""	""	""	"pathogen"	"pathogen"	"pathogen"	""
"evidence"	""	""	""	""	"label"	""	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	""	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"label"	"url"	"label"	"label"	""	""	""	"file"
"role"	""	""	""	"tissue"	"observed"	"cell_biomarker"	"observed"	"observed"	"background"	"measured"	"background"	"observed"	"observed"	"background"	"background"	"vaccine"	"background"	"background"	"background"	"observed"	"background"	"background"	"background"	"background"	"reference"	"background"	"background"	"pathogen"	"pathogen"	"pathogen"	"observed"
"mime_type"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"numeric_units"	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""	""
"display_text"	""	""	""	"tissue type"	"response agent (original)"	"response agent (cell subset)"	"cell type PRO and extra terms"	"all response agents in signature"	"response behavior type"	"response behavior"	"subgroup"	"time point"	"time point units"	"vaccine year"	"exposure material (name)"	"exposure material (VO)"	"additional exposure material"	"comparison"	"baseline time"	"cohort"	"publication reference (PMID)"	"publication year"	"Figure or table or text section containing signature"	"comment"	"Nakaya et al. (2016) Systems biology of immunity to MF59-adjuvanted versus nonadjuvanted trivalent seasonal influenza vaccines in early childhood. Proc. Natl. Acad. Sci. U.S.A. PMID: <a href = 'https://www.ncbi.nlm.nih.gov/pubmed/?term=26755593' target='_blank'>26755593</a>"	"ID of observation within its submission"	"Uniq ID of observation within submission type"	"target pathogen 1"	"target pathogen 2"	"target pathogen 3"	"signature response agents file"
""	"20160722-hipciof_ctf_corr_26755593"	"2016.07.22"	"hipciof_ctf_corr_5"	"peripheral blood mononuclear cell"	"CD4-positive, alpha-beta T cell"	"CD4-positive, alpha-beta T cell"	""	"CD4-positive, alpha-beta T cell"	"cell type frequency"	"positively"	"none"	"56"	"Days"	"2012"	"Fluad"	"VO_0004281"	""	"correlated with antibody response at 28d and onward"	"time of vaccination (first dose)"	"children (14-27mo)"	"26755593"	"2016"	""	""	"https://www.ncbi.nlm.nih.gov/pubmed/?term=26755593"	"1"	"18"	"influenza A virus (A/California/7/2009(H1N1))"	"influenza A virus (A/Victoria/361/2011(H3N2))"	"influenza B virus (B/Wisconsin/01/2010)"	"hipciof_ctf_corr_26755593_18.txt"
